Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01789346 · ClinicalTrials.gov registry record · NA

Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars

A NA study, sponsored by Cutera.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT01789346: Completed NA study, sponsored by Cutera.

NCT01789346 is a NA study that has completed, run by Cutera. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01789346, a NA study, has completed, sponsored by Cutera.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the safety and efficacy of the 532nm potassium titanyl phosphate (KTP) laser in comparison with the 595nm pulsed-dye laser (PDL) for the treatment of fresh surgical scars.

Primary Outcome

Improvement in surgical scar of 532 nm KTP and 595 nm PDL treatment arms at 12 weeks post-final treatment (compared to baseline) as assessed by blinded independent reviewers Physician's Global Assessment (min=0; max=3) Higher scores mean better outcome

Interventions

  • DEVICE 532nm KTP
  • DEVICE 595nm PDL

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2013-02
Est. Completion 2014-12
Phase NA
Cutera

37 total trials

What the finished NCT01789346 record still lists

NCT01789346 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which 532nm KTP is the first listed.

NCT01789346 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01789346 about?

NCT01789346 is a clinical study titled "Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars". The purpose of this study is to evaluate the safety and efficacy of the 532nm potassium titanyl phosphate (KTP) laser in comparison with the 595nm pulsed-dye laser (PDL) for the treatment of fresh surgical scars.

What is the current status of trial NCT01789346?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-02. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01789346?

The interventions under investigation include: 532nm KTP (DEVICE), 595nm PDL (DEVICE).

Who is sponsoring clinical trial NCT01789346?

This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01789346's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01789346, the US trial registry maintained by the National Library of Medicine. NCT01789346 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.